Legal Issues

Pfizer subsidiary found liable in Rezulin case

Published in Drug Week, May 9th, 2003

A jury in Manhattan, New York, returned a verdict in the amount of $2 million against Warner-Lambert, a wholly owned subsidiary of Pfizer, Inc., (PFE) on behalf of plaintiff Concepcion Morgado.

According to the lawfirm Seeger Weiss, LLP, Morgado, a type-2 diabetic, was injured as a result of taking the Warner-Lambert diabetes drug, Rezulin. Rezulin was withdrawn from the market in March of 2000.

The jury unanimously found by "clear and convincing" evidence that Warner-Lambert misrepresented or omitted material information about Rezulin to physicians, including Morgado's physician.

The jury further found that Warner-Lambert showed...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2003-05-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry